(1)要約中間連結純損益計算書

(単位:百万円)

 

 

前中間連結会計期間

(自 2024年4月1日

至 2024年9月30日)

 

当中間連結会計期間

(自 2025年4月1日

至 2025年9月30日)

売上収益

 

935,621

 

1,030,114

売上原価

 

173,825

 

200,359

売上総利益

 

761,795

 

829,755

 

 

 

 

 

販売費及び一般管理費

 

406,411

 

403,834

研究開発費

 

172,330

 

143,289

無形資産償却費

 

69,231

 

65,489

無形資産譲渡益

 

909

 

4,011

持分法による投資損益

 

1,448

 

1,582

その他の収益

 

4,473

 

5,188

その他の費用

 

26,945

 

25,381

営業利益

 

93,710

 

199,378

 

 

 

 

 

金融収益

 

4,874

 

3,819

金融費用

 

9,543

 

8,591

税引前中間利益

 

89,042

 

194,606

法人所得税費用

 

15,531

 

46,971

中間利益

 

73,511

 

147,635

 

 

 

 

 

中間利益の帰属

 

 

 

 

親会社の所有者

 

73,511

 

147,635

 

 

 

 

 

1株当たり中間利益

 

 

 

 

基本的1株当たり中間利益(円)

 

41.06

 

82.44

希薄化後1株当たり中間利益(円)

 

40.91

 

82.17

 

E00920 45030 アステラス製薬株式会社 Astellas Pharma Inc. 四半期第7号参考様式 [IFRS](連結)(一般2Q) IFRS true cte 2025-04-01 2025-09-30 HY 2026-03-31 2024-04-01 2024-09-30 2025-03-31 1 false false false 45030 2025-10-30 45030 2025-04-01 2025-09-30 45030 2025-04-01 2025-09-30 jpigp_cor:CapitalSurplusIFRSMember 45030 2025-04-01 2025-09-30 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45030 2025-04-01 2025-09-30 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45030 2025-04-01 2025-09-30 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45030 2025-04-01 2025-09-30 jpigp_cor:OtherComponentsOfEquityIFRSMember 45030 2025-04-01 2025-09-30 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45030 2025-04-01 2025-09-30 jpigp_cor:RetainedEarningsIFRSMember 45030 2025-04-01 2025-09-30 jpigp_cor:ShareAcquisitionRightsIFRSMember 45030 2025-04-01 2025-09-30 jpigp_cor:ShareCapitalIFRSMember 45030 2025-04-01 2025-09-30 jpigp_cor:TreasurySharesIFRSMember 45030 2025-09-30 45030 2025-09-30 jpigp_cor:CapitalSurplusIFRSMember 45030 2025-09-30 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45030 2025-09-30 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45030 2025-09-30 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45030 2025-09-30 jpigp_cor:OtherComponentsOfEquityIFRSMember 45030 2025-09-30 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45030 2025-09-30 jpigp_cor:RetainedEarningsIFRSMember 45030 2025-09-30 jpigp_cor:ShareAcquisitionRightsIFRSMember 45030 2025-09-30 jpigp_cor:ShareCapitalIFRSMember 45030 2025-09-30 jpigp_cor:TreasurySharesIFRSMember 45030 2024-04-01 2024-09-30 45030 2024-04-01 2024-09-30 jpigp_cor:CapitalSurplusIFRSMember 45030 2024-04-01 2024-09-30 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45030 2024-04-01 2024-09-30 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45030 2024-04-01 2024-09-30 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45030 2024-04-01 2024-09-30 jpigp_cor:OtherComponentsOfEquityIFRSMember 45030 2024-04-01 2024-09-30 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45030 2024-04-01 2024-09-30 jpigp_cor:RetainedEarningsIFRSMember 45030 2024-04-01 2024-09-30 jpigp_cor:ShareAcquisitionRightsIFRSMember 45030 2024-04-01 2024-09-30 jpigp_cor:ShareCapitalIFRSMember 45030 2024-04-01 2024-09-30 jpigp_cor:TreasurySharesIFRSMember 45030 2024-09-30 45030 2024-09-30 jpigp_cor:CapitalSurplusIFRSMember 45030 2024-09-30 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45030 2024-09-30 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45030 2024-09-30 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45030 2024-09-30 jpigp_cor:OtherComponentsOfEquityIFRSMember 45030 2024-09-30 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45030 2024-09-30 jpigp_cor:RetainedEarningsIFRSMember 45030 2024-09-30 jpigp_cor:ShareAcquisitionRightsIFRSMember 45030 2024-09-30 jpigp_cor:ShareCapitalIFRSMember 45030 2024-09-30 jpigp_cor:TreasurySharesIFRSMember 45030 2025-03-31 45030 2025-03-31 jpigp_cor:CapitalSurplusIFRSMember 45030 2025-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45030 2025-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45030 2025-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45030 2025-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45030 2025-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45030 2025-03-31 jpigp_cor:RetainedEarningsIFRSMember 45030 2025-03-31 jpigp_cor:ShareAcquisitionRightsIFRSMember 45030 2025-03-31 jpigp_cor:ShareCapitalIFRSMember 45030 2025-03-31 jpigp_cor:TreasurySharesIFRSMember 45030 2024-03-31 45030 2024-03-31 jpigp_cor:CapitalSurplusIFRSMember 45030 2024-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45030 2024-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45030 2024-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45030 2024-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45030 2024-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45030 2024-03-31 jpigp_cor:RetainedEarningsIFRSMember 45030 2024-03-31 jpigp_cor:ShareAcquisitionRightsIFRSMember 45030 2024-03-31 jpigp_cor:ShareCapitalIFRSMember 45030 2024-03-31 jpigp_cor:TreasurySharesIFRSMember iso4217:JPY iso4217:JPY xbrli:shares xbrli:pure